The biopharma ecosystem stands at a crossroads. With anemic R&D delivery, failed clinical trials, access challenges, declining valuations, escalating clinical trial costs, patient identification, the hurdles we face are significant. We invite you to join leading experts from academia, biopharma, and the investment community to discuss strategies to navigate these in oncology and rare diseases.

To secure your seat at this important discussion, we suggest a donation of $50 to Axiom REACH Foundation. The Axiom REACH Foundation is dedicated to addressing public health disparities by supporting underserved patients, families, and communities facing life-altering, incurable diagnoses.

Your contribution will help Axiom meet essential needs for cancer and rare disease patients, covering expenses such as rent, utilities, groceries, and hospice care.

 

Axiom REACH Foundation
Questions: Tahsin Nabid

Donate Now

Help us support patients as they seek rent, utilities, groceries, and hospice care - every bit counts!

Your contribution will help Axiom meet essential needs for cancer and rare disease patients, covering expenses such as rent, utilities, groceries, and hospice care.